Author:
Wang Biqi,Dron Jacqueline S.,Wang Yuxuan,Choi Seung Hoan,Huffman Jennifer E.,Cho Kelly,Wilson Peter W. F.,Natarajan Pradeep,Peloso Gina M.
Abstract
AbstractPrevious studies found lipid levels, especially triglycerides (TG), are associated with acute pancreatitis, but their causalities and bi-directions were not fully examined. We determined whether abnormal levels of TG, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) are precursors and/or consequences of acute pancreatitis using bidirectional two-sample Mendelian randomization (MR) with two non-overlapping genome-wide association study (GWAS) summary statistics for lipid levels and acute pancreatitis. We found phenotypic associations that both higher TG levels and lower HDL-C levels contributed to increased risk of acute pancreatitis. Our GWAS meta-analysis of acute pancreatitis identified seven independent signals. Genetically predicted TG was positively associated with acute pancreatitis when using the variants specifically associated with TG using univariable MR [Odds ratio (OR), 95% CI 2.02, 1.22–3.31], but the reversed direction from acute pancreatitis to TG was not observed (mean difference = 0.003, SE = 0.002, P-value = 0.138). However, a bidirectional relationship of HDL-C and acute pancreatitis was observed: A 1-SD increment of genetically predicted HDL-C was associated with lower risk of acute pancreatitis (OR, 95% CI 0.84, 0.76–0.92) and genetically predisposed individuals with acute pancreatitis have, on average, 0.005 SD lower HDL-C (mean difference = − 0.005, SE = 0.002, P-value = 0.004). Our MR analysis confirms the evidence of TG as a risk factor of acute pancreatitis but not a consequence. A potential bidirectional relationship of HDL-C and acute pancreatitis occurs and raises the prospect of HDL-C modulation in the acute pancreatitis prevention and treatment.
Funder
Veterans Affairs Merit Award
NIH
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Gupta, A. et al. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial. Lancet 392(10153), 1127–1137 (2018).
2. Ference, B. A., Graham, I., Tokgozoglu, L. & Catapano, A. L. Impact of lipids on cardiovascular health: JACC health promotion series. J. Am. Coll. Cardiol. 72(10), 1141–1156 (2018).
3. Li, Y. et al. Association between high-density lipoprotein cholesterol and apolipoprotein A-I and severe acute pancreatitis: a case-control study. Eur. J. Gastroenterol. Hepatol. 33(12), 1517–1523 (2021).
4. Yang, A. L. & McNabb-Baltar, J. Hypertriglyceridemia and acute pancreatitis. Pancreatol. Off. J. Int. Assoc. Pancreatol. 20(5), 795–800 (2020).
5. Hansen, S. E. J., Madsen, C. M., Varbo, A., Tybjærg-Hansen, A. & Nordestgaard, B. G. Genetic variants associated with increased plasma levels of triglycerides, via effects on the lipoprotein lipase pathway, increase risk of acute pancreatitis. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 19(8), 1652-1660.e6 (2021).